エピソード

  • Krutika Kuppalli and Placeide Mbala on Bunidbugyo virus
    2026/10/28

    Krutika Kuppali and Placide Mabala talk about the development control measures, diagnostic tests, and therapies for the current Bundibugyo outbreak in the Democratic Republic of the Congo.

    The Lancet Infectious Diseases in conversation with... is part of the Lancet Group podcast offering.

    Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall

    Podcast editing: Matteo Simonetti

    Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.

    Find the best science for better lives at lancet.com Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

    続きを読む 一部表示
    25 分
  • Fernando Tortosa and Ariel Izcovich on hantavirus infections
    2026/07/24

    Fernando Tortosa and Ariel Izcovich discuss various aspects of hantavirus infections with a focus on the situation in Argentina, including transmission, epidemiology, clinical course, management, latest research developments, difficulties in conducting clinical trials, and future research priorities. The speakers also discuss the main findings and clinical implications of a study 'Use of tocilizumab for severe hantavirus pulmonary syndrome: a MEURI case series with contextual comparisons' they recently published in the journal.

    Click here to read the full article:

    https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00285-9/abstract

    The Lancet Infectious Diseases in conversation with... is part of the Lancet Group podcast offering.

    Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall

    Podcast editing: Matteo Simonetti

    Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.

    Find the best science for better lives at lancet.com Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

    続きを読む 一部表示
    24 分
  • Brecht Ingelbeen and Daniel Valia on a community-based antimicrobial stewardship intervention in Burkina Faso and DRC
    2026/06/15

    Dr Brecht Ingelbeen and Dr Daniel Valia join Senior Editor Phoebe Hall to discuss a new trial in the journal (the CABU-EICO trial) testing a co-created behavioural intervention bundle to improve antibiotic use, patient management, and water, sanitation and hygiene in rural communities in Burkina Faso and DR Congo. They explain why the study focused on community prescribing (not hospitals), the primary endpoint was a reduction in WHO AWaRE Watch antibiotics (not overall antibiotics), and the intervention targeted all providers of antibiotics in the community, including informal vendors.

    Finally, they discuss the importance of designing an intervention bundle that was truly tailored to local context yet practical, sustainable, and scalable beyond the study sites. A parallel study reporting the effect of the intervention bundle on ESBL-producing Escherichia coli colonisation (a co-primary outcome of the trial) is in press at The Lancet Microbe.

    To read the full article:

    https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00169-6/fulltext

    The Lancet Infectious Diseases in conversation with... is part of the Lancet Group podcast offering.

    Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall

    Podcast editing: Matteo Simonetti

    Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.

    Find the best science for better lives at lancet.com Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

    続きを読む 一部表示
    27 分
  • Sara Tartof and Matan Yechezkel on durability of doxycycline effectiveness against syphilis, gonorrhoea, and chlamydia after implementation of post-exposure prophylaxis in southern California
    2026/05/07

    Sara Tartof and Matan Yechezkel discuss a new article in The Lancet Infectious Diseases about emerging doxycycline resistance against gonorrhoea and its wider implications for the implementation of doxycycline and the prevention of bacterial sexually transmitted infections.

    Click here to read the full article:

    https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00123-4/fulltext

    The Lancet Infectious Diseases in conversation with... is part of the Lancet Group podcast offering.

    Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall

    Podcast editing: Matteo Simonetti

    Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.

    Find the best science for better lives at lancet.com Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

    続きを読む 一部表示
    26 分
  • Jenny Clarke and Herve Semukunzi
    2026/03/09

    Dr Jenny Clarke and Herve Semukunzi discuss a study they and colleagues recently published with us titled ‘Infection- and vaccine-induced mpox antibodies: validation of a combined mpox IgG ELISA during the clade 1b outbreak in Rwanda’.

    They also discuss the reasons for the paucity of validated serological assays for mpox, particularly in outbreak regions where they are most urgently needed.

    Click here to read the full article:

    https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00006-X/fulltext

    Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

    The Lancet Infectious Diseases in conversation with... is part of the Lancet Group podcast offering.

    Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall

    Podcast editing: Matteo Simonetti

    Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.

    Find the best science for better lives at lancet.com Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

    続きを読む 一部表示
    21 分
  • Julia Moore Vogel and Danilo Buonsenso on long COVID
    2025/12/19

    Dr Julia Moore Vogel and Dr Danilo Buonsenso discuss various aspects of long COVID including epidemiology, pathophysiology, underlying mechanisms, management, latest research developments, difficulties in conducting clinical trials, and future research priorities.

    Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

    The Lancet Infectious Diseases in conversation with... is part of the Lancet Group podcast offering.

    Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall

    Podcast editing: Matteo Simonetti

    Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.

    Find the best science for better lives at lancet.com Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

    続きを読む 一部表示
    28 分
  • In Conversation with Steven Tong and Joshua Davis on adaptive platform trials
    2025/10/23

    Professors Steven Tong and Joshua Davis discuss all aspects of adaptive platform trials including advantages, disadvantages, differences from conventional trials, and tips for setting up and assessing them.

    They also highlight several adaptive platform trials currently in the pipeline that could influence infectious disease clinical practise in the future.

    Click here to read our latest issue

    Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

    The Lancet Infectious Diseases in conversation with... is part of the Lancet Group podcast offering.

    Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall

    Podcast editing: Matteo Simonetti

    Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.

    Find the best science for better lives at lancet.com Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

    続きを読む 一部表示
    26 分
  • Anna Odone, Jesus Rodriguez-Manzano, and Alex Howard on artificial intelligence and infectious diseases
    2025/09/16

    Professor Ana Odone, Dr Jesus Rodriguez-Manzano, and Dr Alex Howard discuss their new Series of papers on artificial intelligence and infectious diseases intended to support the infectious diseases community in understanding this evolving landscape and in actively shaping artificial intelligence integration into practice.

    Read the full Series here:

    https://www.thelancet.com/series-do/artificial-intelligence-and-infectious-diseases?dgcid=buzzsprout_icw_podcast_laninfaiandid25_laninf

    Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

    The Lancet Infectious Diseases in conversation with... is part of the Lancet Group podcast offering.

    Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall

    Podcast editing: Matteo Simonetti

    Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.

    Find the best science for better lives at lancet.com Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

    続きを読む 一部表示
    29 分